Conflicts of
interest
Christian Vogelberg reports consulting fees and/or payment or honoraria
for lectures, presentations or speakers bureaus from Allergy
Therapeutics, Bencard Allergie, Allergopharma, HAL Allergy, Stallergenes
Greer, Novartis Pharma, LETI Pharma, DBV Technology, Aimmune, Sanofi
Aventis, ALK-Abelló, Memberships: AeDA, GPA, APPA, DGAKI, EAACI.
Ludger Klimek reports grants, institutional fees and/or institutional
payment for expert testimony from Allergopharma, Viatris, Stallergenes
Greer, GSK, Sanofi, Leti Pharma, HAL Allergy, ALK-Abelló, Quintiles,
ASIT biotech, Lofarma, AstraZeneca, Inmunotek, Allergy Therapeutics,
Cassella med, Novartis, Regeneron Pharmaceuticals, Roxall Medizin GmbH;
Memberships: AeDA, DGHNO, Deutsche Akademie für Allergologie und
klinische Immunologie, HNO-BV, GPA, EAACI.
Bernd Brüggenjürgen reports payment or honoraria for lectures,
presentations, speakers bureaus, manuscript writing or educational
events from IQVIA, outside the submitted work.
Marek Jutel reports consulting fees and/or payment or honoraria for
lectures, presentations, speakers bureaus, manuscript writing or
educational events from Allergopharma, Stallergenes Greer, ALK Abelló,
Chiesi, HAL Allergy, GSK; Leadership or fiduciary role in other board,
society, committee or advocacy group, paid or unpaid: EAACI, Fundacja
Centrum Walki z Alergia.